BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 38671506)

  • 1. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice.
    Freeman E; Langlois S; Leyba MF; Ammar T; Léger Z; McMillan HJ; Renaud JM; Jasmin BJ; Cowan KN
    Skelet Muscle; 2024 Apr; 14(1):8. PubMed ID: 38671506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.
    Cea LA; Puebla C; Cisterna BA; Escamilla R; Vargas AA; Frank M; Martínez-Montero P; Prior C; Molano J; Esteban-Rodríguez I; Pascual I; Gallano P; Lorenzo G; Pian H; Barrio LC; Willecke K; Sáez JC
    Cell Mol Life Sci; 2016 Jul; 73(13):2583-99. PubMed ID: 26803842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satellite Cells in Muscular Dystrophy - Lost in Polarity.
    Chang NC; Chevalier FP; Rudnicki MA
    Trends Mol Med; 2016 Jun; 22(6):479-496. PubMed ID: 27161598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor interacting protein kinase-3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy.
    Bencze M; Periou B; Punzón I; Barthélémy I; Taglietti V; Hou C; Zaidan L; Kefi K; Blot S; Agbulut O; Gervais M; Derumeaux G; Authier FJ; Tiret L; Relaix F
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2520-2531. PubMed ID: 37909859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucocorticoid receptor acts locally to protect dystrophic muscle and heart during disease.
    Oliver T; Nguyen NY; Tully CB; McCormack NM; Sun CM; Fiorillo AA; Heier CR
    Dis Model Mech; 2024 May; 17(5):. PubMed ID: 38770680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the
    Wright CR; Allsopp GL; Addinsall AB; McRae NL; Andrikopoulos S; Stupka N
    Mediators Inflamm; 2017; 2017():7043429. PubMed ID: 28592916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe cardiac and skeletal manifestations in DMD-edited microminipigs: an advanced surrogate for Duchenne muscular dystrophy.
    Otake M; Imamura M; Enya S; Kangawa A; Shibata M; Ozaki K; Kimura K; Ono E; Aoki Y
    Commun Biol; 2024 May; 7(1):523. PubMed ID: 38702481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration.
    Budzynska K; Siemionow M; Stawarz K; Chambily L; Siemionow K
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD.
    Hicks MR; Liu X; Young CS; Saleh K; Ji Y; Jiang J; Emami MR; Mokhonova E; Spencer MJ; Meng H; Pyle AD
    J Nanobiotechnology; 2023 Aug; 21(1):303. PubMed ID: 37641124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-tiered hypotheses for Duchenne muscular dystrophy.
    Grounds MD
    Cell Mol Life Sci; 2008 Jun; 65(11):1621-5. PubMed ID: 18327663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucyl-tRNA Synthetase Contributes to Muscle Weakness through Mammalian Target of Rapamycin Complex 1 Activation and Autophagy Suppression in a Mouse Model of Duchenne Muscular Dystrophy.
    You JS; Karaman K; Reyes-Ordoñez A; Lee S; Kim Y; Bashir R; Chen J
    Am J Pathol; 2024 May; ():. PubMed ID: 38762116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation.
    Coenen-Stass AM; Betts CA; Lee YF; Mäger I; Turunen MP; El Andaloussi S; Morgan JE; Wood MJ; Roberts TC
    Hum Mol Genet; 2016 Sep; 25(18):3960-3974. PubMed ID: 27466195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin: The dead calm of a dogma.
    Górecki DC
    Rare Dis; 2016; 4(1):e1153777. PubMed ID: 27141413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of pannexin and connexin channels and their functional role in skeletal muscles.
    Sáez JC; Cisterna BA; Vargas A; Cardozo CP
    Cell Mol Life Sci; 2015 Aug; 72(15):2929-35. PubMed ID: 26084874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory characterization of a humanized Duchenne muscular dystrophy mouse model.
    Roger AL; Biswas DD; Huston ML; Le D; Bailey AM; Pucci LA; Shi Y; Robinson-Hamm J; Gersbach CA; ElMallah MK
    Respir Physiol Neurobiol; 2024 May; 326():104282. PubMed ID: 38782084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division.
    Dumont NA; Wang YX; von Maltzahn J; Pasut A; Bentzinger CF; Brun CE; Rudnicki MA
    Nat Med; 2015 Dec; 21(12):1455-63. PubMed ID: 26569381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyoSight-semi-automated image analysis of skeletal muscle cross sections.
    Babcock LW; Hanna AD; Agha NH; Hamilton SL
    Skelet Muscle; 2020 Nov; 10(1):33. PubMed ID: 33198807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative ultrasonography reveals skeletal muscle abnormalities in carriers of DMD pathogenic variants.
    Loureiro BMC; de Brito MR; Iwabe C; Dertkigil SSJ; França MC
    Muscle Nerve; 2024 Jun; 69(6):682-690. PubMed ID: 38517116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pannexin 1 channel is not phosphorylated by Src tyrosine kinase at Tyr199 and Tyr309.
    Ruan Z; Lee J; Li Y; Du J; Lü W
    Elife; 2024 May; 13():. PubMed ID: 38780416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a Ketogenic Diet on the Assessment of Biochemical and Clinical Parameters in Duchenne Muscular Dystrophy: A Preclinical Investigation.
    Fausto LL; Alberti A; Kades G; de Carvalho RPD; Freiberger V; Ventura L; Dias P; Zanoni EM; Soares BH; Dutra ML; Martins DF; Comim CM
    Mol Neurobiol; 2024 May; ():. PubMed ID: 38816675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.